Top news of the week: 20.05.2021.
Career And Jobs
EureKARE raises $60M to create EU synbio and microbiome startups
EureKARE has raised a $60 million series A round to fund the creation and advancement of synthetic biology and microbiome startups. The cash will enable eureKARE to build companies around ...
Tamasek-Backed G2 Bio Companies Will Accelerate Gene Transfer Technologies
Temasek has committed $200 million to launch The G2 Bio Companies which focuses on the development of potential next-generation gene therapies.
Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant
Thermo Fisher and the University of California partnered with the development and manufacturing of cell-based therapies with the construction of its 44,000 sq. ft. manufacturing facility.
Philadelphia, Pacific Northwest See Surge in Biopharma Jobs
Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here’s a look.
Infographic: Quality assurance career path
How to grow your career in quality assurance Quality assurance is an important part of the life sciences product development cycle. Careers in...
Biopharma Execs Address the Challenges of a Post-Pandemic Workplace
If these companies are any indication, it appears that the biopharma industry will be a hybrid of virtual and physical workforces, and with this comes a whole new set of risks.
Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech
Novartis Institutes for Biomedical Research is bleeding leaders as a third in as many weeks exits the door to lead Tevard Biosciences into the clinic.
CytoDyn shares plummet after FDA blasts the biotech for cherry picking COVID-19 data
In an unprecedented public rebuke, the FDA accused CytoDyn of trying to cherry pick data from two failed studies of leronlimab in COVID-19 patients to claim the drug is effective. ...